After-hours movers: Docusign, Ulta Beauty, Rubrik and more

William Blair Reiterates Market Perform Rating on Docusign Inc. (DOCU)

William Blair analyst Bhavan Suri reiterated a Market Perform rating on Docusign Inc. (NASDAQ: DOCU)

The analyst comments "DocuSign reported solid fourth-quarter results that outperformed consensus estimates on most key metrics. In our view, highlights from the quarter included subscription revenue growth of 9%, which beat the Street by 180 basis points; a continued acceleration in billings growth; and solid adoption of IAM, which represented 20% of direct new customer deals during the quarter. While IAM was only recently made available to... More

Wells Fargo Reiterates Underweight Rating on Docusign Inc. (DOCU), PT $73

Wells Fargo analyst Michael Turrin reiterated an Underweight rating and $73.00 price target on Docusign Inc. (NASDAQ: DOCU)

The analyst comments "Thoughts on Initial FY26 Guide: DOCU provided initial FY26 guidance of 5-6% total rev growth, ~6% subs rev growth, 6-7% billings growth, and 28.3% OM vs prior st ests of... More

RBC Capital Reiterates Sector Perform Rating on Docusign Inc. (DOCU)

RBC Capital analyst Rishi Jaluria reiterated a Sector Perform rating and $90.00 price target on Docusign Inc. (NASDAQ: DOCU)

The analyst comments "DocuSign reported a solid quarter with strong billings growth leading shares up 11% after-hours. NRR grew again 1-pt to 101% while billings came in... More

Piper Sandler Reiterates Neutral Rating on Docusign Inc. (DOCU)

Piper Sandler analyst Rob Owens reiterated a Neutral rating and $90.00 price target on Docusign Inc. (NASDAQ: DOCU)

The analyst comments "F'4Q results were solid with both revenue & billings showing upside to guidance. Management highlighted continued traction with IAM and large customers (+56 net... More

Evercore ISI Maintains Docusign Inc. (DOCU) at In Line

(Updated - March 14, 2025 6:50 AM EDT)

Evercore ISI analyst Kirk Materne maintains coverage on Docusign Inc. (NASDAQ: DOCU) with a In Line rating and a price target of $100.00.

The analyst comments "DocuSign delivered a solid finish to FY25, highlighted by total revenue growth of 9% vs. our/Street estimates of ~7, and billings growth of ~11% nicely above our/Street estimates of ~5%. F1Q/FY26 revenue guidance of ~5-5.5% at the midpoint was a touch below Street estimates but inclusive of a ~170bps headwind for F1Q (1pt for lapping leap year... More

Jefferies Reiterates Buy Rating on Docusign Inc. (DOCU)

Jefferies analyst Brent Thill reiterated a Buy rating and $115.00 price target on Docusign Inc. (NASDAQ: DOCU)

The analyst comments "What We Liked: 1) Nice FQ4 beat: Subs $758M (8.9% growth) vs. St. $743M (6.8%), total rev 9.0% y/y vs. St. 6.8%, op mgn 28.8% vs. St. 28.0%. 2) Strong billings: Billings grew 10.8% vs. St. 5.0%, with beat driven by early renewals, IAM, and more annual billing terms. 3) IAM momentum. IAM accounted for >20% of direct new customer deals and LSD% of the total subs recurring rev book of business, which is expected to jump to LDD% by F4Q26. 4) Improved DNR,... More

Wolfe Research Reiterates Peerperform Rating on Docusign Inc. (DOCU)

Wolfe Research analyst Alex Zukin reiterated a Peerperform rating and {REMOVEPT} price target on Docusign Inc. (NASDAQ: DOCU)

The analyst comments "DOCU (once again) delivered strong F4Q25 results, with (once again) all metrics coming in ahead of guidance and FY26 guidance exceeding consensus growth expectations (after adjusting for FX) with accelerating billings growth. F4Q25 billings accelerated +11% to $923M (+5% vs. consensus), with half of the outperformance driven by early renewals and the remaining beat driven by IAM outperformance and... More

Docusign Inc. (DOCU) PT Lowered to $98 at BofA Securities

BofA Securities analyst Brad Sills lowered the price target on Docusign Inc. (NASDAQ: DOCU) to $98.00 (from $112.00) while maintaining a Neutral rating.

The analyst comments "We are encouraged by solid Q4 results, which suggest DocuSign is executing well on growth initiatives to drive a healthy... More

Morgan Stanley Reiterates Equalweight Rating on Docusign Inc. (DOCU)

Morgan Stanley analyst Josh Baer reiterated an Equalweight rating and $97.00 price target on Docusign Inc. (NASDAQ: DOCU).

The analyst comments "Bull Case Coming into View? Docusign reported a meaningful Q4 upside surprise with billings growth of 11% YoY against guidance for 5%, a tough YoY comp, and buyside expectations of high-single digit growth. Furthermore, FY26 billing guidance of 7% YoY (8% constant currency) was initiated ahead of consensus' 6% estimate. While bears push back on the Q4... More

ULTA Beauty (ULTA) PT Lowered to $327 at Barclays

Barclays analyst Adrienne Yih lowered the price target on ULTA Beauty (NASDAQ: ULTA) to $327.00 (from $445.00) while maintaining a Equalweight rating.

The analyst comments "2025 A Transition Year. ULTA's 4Q24 beat on sales, GM, SG&A, OM, and EPS. However, its FY25 guidance came in below vs. consensus, as the macro backdrop remains uncertain and the company pursues its Ulta Beauty Unleash plan to rebase the business. 4Q24 results... More

Guggenheim Reiterates Buy Rating on Rubrik Inc (RBRK)

Guggenheim analyst John DiFucci reiterated a Buy rating and $76.00 price target on Rubrik Inc (NYSE: RBRK).

The analyst comments "Key Message: RBRK reported F4Q25 business momentum that was above that of any other company in our coverage universe, with New Subscription ARR growth of 52% and New Total ARR growth of 66% (see Exhibit 1). The company is now also getting more scale in renewals, which has helped margins, as FCF finished positive for the year (e.g., +$21.6,... More

ULTA Beauty (ULTA) PT Lowered to $450 at Raymond James

Raymond James analyst Olivia Tong lowered the price target on ULTA Beauty (NASDAQ: ULTA) to $450.00 (from $495.00) while maintaining a Outperform rating.

The analyst comments "ULTAs F4Q24 comp +1.5% y/y, driven by double-digit growth in Fragrance, was a solid acceleration, while... More

ULTA Beauty (ULTA) PT Lowered to $354 at Jefferies

Jefferies analyst Ashley Helgans lowered the price target on ULTA Beauty (NASDAQ: ULTA) to $354.00 (from $412.00) while maintaining a Hold rating.

The analyst comments "Q4 results were ahead of expectations, but macro and competitive pressures drove FY guide below street ests. FY comps... More

Docusign Inc. (DOCU) PT Raised to $115 at Citi

Citi analyst Tyler Radke raised the price target on Docusign Inc. (NASDAQ: DOCU) to $115.00 (from $113.00) while maintaining a Buy rating.

The analyst comments "DocuSign continues to show signs of re-accelerating growth trends, with another strong +5pt billings beats along with re-accelerating subscription revenue... More

ULTA Beauty (ULTA) PT Lowered to $415 at DA Davidson

DA Davidson analyst Michael Baker lowered the price target on ULTA Beauty (NASDAQ: ULTA) to $415.00 (from $510.00) while maintaining a Buy rating.

The analyst comments "ULTA dodged most of the bullets, beating the quarter on sales and profits, and giving guidance that while... More